Surgical Science Sweden AB (publ) (SUS.ST) Research

Surgical Science Sweden AB (publ) specializes in the creation and distribution of virtual reality (VR) simulation platforms designed for evidence-backed training in laparoscopic and endoscopic procedures. Among its key offerings is the LapSim training system, which includes LapSim ST, tailored for educating surgical technologists and assistants, as well as LapSim essence, a compact and readily deployable VR simulator. The company's product portfolio further extends to the EndoSim system, a dedicated endoscopy simulator for comprehensive medical training. It also features TeamSim, an innovative platform fostering inter-professional education by integrating surgical simulation with real-world team dynamics. Additionally, they provide the Simball Box, which delivers velocity feedback alongside instructional task videos demonstrating optimal techniques, alongside their well-known Simbionix and robotic surgery simulators. Established in 1999, Surgical Science AB maintains its headquarters in Gothenburg, Sweden.

Market snapshot

Symbol
SUS.ST
Price
$30.80
Day change
-1.28%
Market cap
$1.6B
P/E ratio
29.90x
52-week range
23.7-162.6
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months

Peer companies

  • Carasent AB (publ) (CARA.ST)
  • CellaVision AB (publ) (CEVI.ST)
  • Flerie AB (publ) (FLERIE.ST)
  • Hansa Biopharma AB (publ) (HNSA.ST)
  • Humana AB (publ) (HUM.ST)
  • Implantica AG (IMP-A-SDB.ST)
  • RaySearch Laboratories AB (publ) (RAY-B.ST)
  • Stille AB (STIL.ST)

Open Surgical Science Sweden AB (publ) (SUS.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.